- Advertisement -
US FDA staff reviewers said there is little evidence to allow compounding pharmacies to manufacture seven popular peptides, in stark contrast to Health Secretary Robert F. Kennedy, Jr., who has publicly endorsed the compounds and said he is a “big fan.”
Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice.
Or get in touch at [email protected]
if you experience difficulties.
